Literature DB >> 17092194

Social anxiety disorder in the primary care setting.

Larry Culpepper1.   

Abstract

Generalized social anxiety disorder (SAD) is a disabling yet unrecognized condition for many individuals visiting primary care physicians. Social anxiety disorder carries a high risk of developing additional anxiety and mood disorders, including those with suicidal behaviors, as comorbidities, leading to a severe course. Screening and case-finding tools are available and can lead to the recognition of affected individuals. Once symptoms are recognized, an initial assessment will help to differentiate from other anxiety disorders and conditions that can be misdiagnosed as SAD. The primary care physician can manage treatment of SAD, which might require involving mental health professionals. Both pharmacotherapy, involving selective serotonin reuptake inhibitors, and psychotherapy, preferably with cognitive-behavioral therapy, can be effective. Long-term support strategies to monitor relapses or the development of additional psychiatric disorders or to provide anticipatory guidance at times of significant life transitions are additional primary care-based activities that can be helpful to the patient with SAD.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17092194

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  5 in total

1.  Social anxiety disorder: radio electric asymmetric conveyor brain stimulation versus sertraline.

Authors:  Vania Fontani; Piero Mannu; Alessandro Castagna; Salvatore Rinaldi
Journal:  Patient Prefer Adherence       Date:  2011-11-22       Impact factor: 2.711

2.  A randomized clinical trial of group and individual Cognitive-Behavioral Therapy approaches for Social Anxiety Disorder.

Authors:  Carmem Beatriz Neufeld; Priscila C Palma; Kátia A S Caetano; Priscila G Brust-Renck; Joshua Curtiss; Stefan G Hofmann
Journal:  Int J Clin Health Psychol       Date:  2019-12-24

3.  Analysis of health-related quality of life and costs based on a randomised clinical trial of escitalopram for relapse prevention in patients with generalised social anxiety disorder.

Authors:  C François; S A Montgomery; N Despiegel; S Aballéa; J Roïz; P Auquier
Journal:  Int J Clin Pract       Date:  2008-08-28       Impact factor: 2.503

4.  Evaluation of the psychometric properties of a modified version of the Social Phobia Screening Questionnaire for use in adolescents.

Authors:  Malin Gren-Landell; Andreas Björklind; Maria Tillfors; Tomas Furmark; Carl Göran Svedin; Gerhard Andersson
Journal:  Child Adolesc Psychiatry Ment Health       Date:  2009-11-11       Impact factor: 3.033

5.  Effect of holistic yoga program on anxiety symptoms in adolescent girls with polycystic ovarian syndrome: A randomized control trial.

Authors:  Ram Nidhi; Venkatram Padmalatha; Raghuram Nagarathna; Ram Amritanshu
Journal:  Int J Yoga       Date:  2012-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.